CVSA Covista Inc. Common Shares
Über Covista Inc. Common Shares Unternehmensübersicht von Wikipedia
Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
Mehr lesen
Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
Before June 2018, the corporation was known as DeVry Education Group Inc. Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017. Adtalem began the process to sell off DeVry University and Keller Graduate School of Management later that year to focus on healthcare professional education. Adtalem subsequently renamed itself Covista in 2026.
History
DeVry Inc. was created in 1987 with the merger of DeVry Institute of Technology (DIT) and the Keller Graduate School of Management. DIT was established in Chicago as the DeForest Training School in 1931 and was acquired by Bell & Howell in 1967. Keller was started by two DIT teachers in 1973; the company acquired DIT from Bell & Howell in 1987. DeVry Inc. went public in 1991, moved to the New York Stock Exchange in 1995, and became known as DeVry Education Group in 2013. The company was previously based in Downers Grove, Illinois.
In 2012, the company moved 150 jobs from its campus in Roscoe Village to a new office in Chicago's West Loop. The company had additional offices in Oak Brook, as of 2013. In 2015, the company opened another office in the West Loop, after the city approved a $1 million subsidy for the company in the form of tax increment financing in 2012.
In November 2013, DeVry Inc. was renamed DeVry Education Group.
Rebranding from DeVry Education Group to Adtalem Global Education
Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017 and began the process to sell off DeVry University and Keller Graduate School of Management later that year. The company stated that the new name signified a renewed focus on professional education in the health care and financial services sectors. Industry analysts characterized the move as an effort to move on from DeVry's legal, financial and reputational challenges.
Inside Higher Ed said, "Even before the new name change, the company has sought to differentiate itself publicly from the rest of the for-profit sector. It has responded to increased regulatory scrutiny -- and negative headlines -- for the sector by announcing self-imposed reforms such as voluntarily limiting the amount of revenue it takes in from federal aid."
The company's headquarters were later relocated from Downers Grove to 500 West Monroe Street in the West Loop Gate. In 2024, Crain's Chicago Business said Adtalem had become "the largest health care educator in the nation during a post-COVID period in which the health care sector has faced severe labor shortages". In November 2024, Adtalem announced plans to expand office capacity by moving to an 84,000-square-foot space in Willis Tower in early 2025. In late 2024, Adtalem partnered with Hippocratic AI to train health care professionals on using artificial intelligence.
Acquisitions and divestitures
Adtalem acquired Becker CPA Review (now known as Becker Professional Education), which prepared students for the Certified Public Accountant exam, in 1996. Adtalem acquired Ross University School of Veterinary Medicine in 2003, Chamberlain University (then Deaconess School of Nursing) in 2005, and American University of the Caribbean in 2011. Adtalem agreed to purchase Walden University for approximately $1.5 billion in September 2020. The agreement required approval by the U.S. Department of Education and the Higher Learning Commission. When the deal closed in August 2021, Adtalem became the largest provider of graduate and undergraduate degrees in nursing.
At the time of the re-branding, approximately half of Adtalem's 225,000 students were based in Brazil and approximately one fifth were studying healthcare. Adtalem went on to divest from the Brazil operations in May 2020.
Adtalem began selling business units unrelated to healthcare education in 2017 and consolidated focus on the industry during 2019–2020, when there was a shortage of health professionals. In 2018, the company sold Carrington College to San Joaquin Valley College, as well as DeVry University to Cogswell Education. In 2019, Kaplan, Inc. acquired Becker's healthcare test preparation assets. Kaplan also agreed to provide Adtalem with U.S. Medical Licensing Examination review programs to Ross University School of Medicine and American University of the Caribbean. In 2022, Colibri Group acquired Becker and OnCourse Learning from Adtalem. Adtalem also sold the Association of Certified Anti-Money Laundering Specialists to the French investment company Wendel. The specific purchase terms were not disclosed, but Adtalem confirmed that its financial services segment, which included ACAMLS, Becker, and OnCourse, sold for $1 billion. Since selling its financial services education business, Adtalem has focused primarily on healthcare education.
Operations
Campuses and enrollment
Adtalem's institutions operated approximately 130 campuses globally in 2018. Twelve of the 90 U.S. campuses were located in Illinois. In 2020, Adtalem's businesses operated 26 campuses in four countries and fifteen U.S. states. Approximately 90,000 students attended schools with a combined 6,100 faculty members. According to Adtalem, 34 percent of the students were Black. The company also claimed to be the largest provider of Master's, doctorate, and nursing degrees for African Americans. As of 2021, approximately 82 percent of the 140,000 students enrolled at Adtalem schools learned via distance education. In 2022, Adtalem operated 27 campuses and offered courses in 209 countries and territories.
Leadership
Stephen Beard, who was previously Adtalem's chief operating officer, became the chief executive officer (CEO) in 2021. He was appointed the chair of the board of directors in November 2024, succeeding Michael W. Malafronte. Beard was included in Time magazine's 2025 "Time100 Health" list of influential people in the healthcare industry.
Chris Begley was the board chair in 2016. Daniel Hamburger and Lisa Wardell have previously held the CEO role. Wardell was appointed in 2016. She was the only Black woman to lead a Fortune 1000 company in 2018, according to Crain's Chicago Business. Wardell was also the board chair in 2019. In 2021, an analysis by the University of Illinois Urbana-Champaign ranked Adtalem in the top five Illinois-based public firms for both gender and racial diversity on the board.
Finances
In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students. In 2017, Adtalem lost approximately $4.6 million from the impacts of Hurricane Irma and Hurricane Maria. The company made a profit of $95.6 million in 2019 and lost $85.8 million in 2020, suffering from enrollment declines during the COVID-19 pandemic. In early 2024, Adtalem was targeted by a short seller and the company announced a $300 million repurchase program. In late 2024, Investor's Business Daily said Adtalem saw an average sales growth of fourteen percent over the last three years. For the 2024 fiscal year, Adtalem repurchased 5.446 million shares for approximately $261 million. In May 2025, the repurchase was completed and a new stock buyback program of up to $150 million through May 2028 was launched.
Controversies
Covista, formerly known as DeVry Education Group, has been the subject of numerous investigations and lawsuits alleging that a variety of false or deceptive practices. While the group has generally denied the allegations, several cases led to multi-million dollar settlements.
In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students.
Months after the FTC settlement, DeVry Education Group rebranded as Adtalem Global Education in May 2018. Adtalem rebranded as Covista in 2026.
For-profit higher education in the United States has been the subject of hearings by the United States Senate Committee on Health, Education, Labor, and Pensions. Specifically regarding DeVry, the Committee found that over half of the students enrolled at DeVry in 2008-2009 withdrew by mid-2010. As of 2015, DeVry spent more on marketing than on student instruction.
As of 2013, DeVry Inc. was under investigation by the Attorneys General of the states of Illinois and Massachusetts.
In 2014, accumulated student loan debt from DeVry University and Keller, its graduate school, had reached approximately $12.1 billion.
A lawsuit filed against DeVry alleged deceptive recruiting practices in violation of federal law.
In January 2016, The Federal Trade Commission filed a lawsuit against DeVry Education Group alleging false or misleading advertising. A class action lawsuit was also filed against DeVry Group in US District Court, Northern District of California claiming breaches of contract, good faith and fair dealing, violations of the California Unfair Trade Practices Act, the California False Advertising Act and the California Consumer Legal Remedies Act, and negligent misrepresentations. A confidential settlement was reached.
In May 2016, a shareholder class action lawsuit was filed against DeVry Group, in the US District Court, Northern District of Illinois. The plaintiffs claimed that defendants made false or misleading statements regarding DeVry University's graduate employment rate and the earnings of DeVry University graduates relative to the graduates of other universities and colleges. The case was settled in 2019 for $27.5 million.
In December 2017, a former administrator filed a civil lawsuit number with the Los Angeles Superior Court, seeking relief for a number of causes of action including Retaliation and Wrongful Termination in Violation of Public Policy for complaining about an incentive-based compensation program that rewarded campus deans for recruiting and enrolling students.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
CVSA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
CVSA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag |
|---|---|
| 30. November 2016 | $0,1800 |
| 1. Juni 2016 | $0,1800 |
| 2. Dezember 2015 | $0,1800 |
| 3. Juni 2015 | $0,1800 |
| 3. Dezember 2014 | $0,1800 |
| 4. Juni 2014 | $0,1700 |
| 4. Dezember 2013 | $0,1700 |
| 5. Juni 2013 | $0,1700 |
| 28. November 2012 | $0,1700 |
| 19. Juni 2012 | $0,1500 |
| 6. Dezember 2011 | $0,1500 |
| 16. Juni 2011 | $0,1200 |
| 8. Dezember 2010 | $0,1200 |
| 11. Juni 2010 | $0,1000 |
| 9. Dezember 2009 | $0,1000 |
| 12. Juni 2009 | $0,0800 |
| 10. Dezember 2008 | $0,0800 |
| 17. Juni 2008 | $0,0600 |
| 12. Dezember 2007 | $0,0600 |
| 14. Juni 2007 | $0,0500 |
CVSA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 4 40,0%
- Kauf 5 50,0%
- Halten 1 10,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
4 Analysten · 2026-08-18Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $2.09 | $1.93 | 0.16% |
| 31. März 2026 | $1.98 | $1.76 | 0.22% |
| 31. Dezember 2025 | $2.43 | $2.23 | 0.20% |
| 30. September 2025 | $1.75 | $1.61 | 0.14% |
| 30. Juni 2025 | $1.66 | $1.56 | 0.10% |
| 31. März 2025 | $1.92 | $1.69 | 0.23% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CVSA | $4.24B | 17.7 | 9.3% | 12.9% | 17.8% | — |
| DUOL | $8.18B | 20.5 | 38.7% | 39.9% | 35.6% | 72.2% |
| LAUR | $4.81B | 17.8 | 8.6% | 16.6% | 26.2% | — |
| GHC | — | 16.5 | 2.5% | 5.9% | 6.5% | — |
| LOPE | $4.56B | 21.6 | 7.1% | 19.5% | 28.3% | — |
| LRN | $3.58B | 12.1 | 4.7% | 13.4% | 21.3% | 37.8% |
| BFAM | $5.64B | 30.2 | 9.2% | 6.6% | 14.1% | 23.8% |
| MH | $2.62B | 72.1 | 0.07% | 1.7% | 4.6% | 80.9% |
| PRDO | $1.83B | 12.1 | 24.2% | 18.9% | 16.3% | — |
| STRA | $1.84B | 14.8 | 4.0% | 10.0% | 7.6% | — |
| UTI | $1.77B | 28.8 | 14.1% | 7.5% | 20.3% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B | · | · | · | |
| Cost of Revenue | $834M | $771M | $699M | $648M | $660M | · | · | · | |
| SG&A Expense | $731M | $672M | $633M | $586M | $566M | · | · | · | |
| Operating Expenses | $1.57B | $1.45B | $1.37B | $1.28B | $1.31B | · | · | · | |
| Operating Income | $383M | $342M | $217M | $168M | $77M | · | · | · | |
| Interest Expense | $45M | $52M | $64M | $63M | $129M | · | · | · | |
| Interest Income | · | · | · | · | $4M | · | · | · | |
| Other Non-op | $7M | $9M | $11M | $7M | $1M | · | · | · | |
| Pretax Income | $345M | $299M | $164M | $112M | $-51M | · | · | · | |
| Income Tax | $78M | $66M | $26M | $10M | $-16M | · | · | · | |
| Net Income | $252M | $237M | $137M | $93M | $311M | · | · | · | |
| EPS (Basic) | $7.18 | $6.39 | $3.47 | $2.08 | $6.43 | · | · | · | |
| EPS (Diluted) | $7.04 | $6.18 | $3.39 | $2.05 | $6.43 | · | · | · | |
| Shares (Basic) | 35,045,000 | 37,085,000 | 39,413,000 | 44,781,000 | 48,388,000 | · | · | · | |
| Shares (Diluted) | 35,715,000 | 38,334,000 | 40,307,000 | 45,600,000 | 48,388,000 | · | · | · | |
| EBITDA | $383M | $342M | $217M | $168M | $80M | · | · | · |
Bilanz 28
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $406M | $200M | $219M | $272M | $347M | $275M | $416M | $67M | |
| Short-term Investments | · | · | · | · | · | · | · | $9M | |
| Receivables | $167M | $143M | $124M | $100M | $79M | $90M | $69M | · | |
| Prepaid Expense | $75M | $69M | $70M | $102M | $128M | $167M | $97M | $45M | |
| Current Assets | $652M | $416M | $418M | $480M | $557M | $611M | $681M | $390M | |
| PP&E (Net) | $303M | $256M | $249M | $245M | $290M | $302M | $279M | $282M | |
| PP&E (Gross) | $686M | $598M | $575M | $583M | $666M | $663M | $618M | $605M | |
| Accum. Depreciation | $383M | $342M | $326M | $339M | $376M | $362M | $339M | $323M | |
| Goodwill | $961M | $961M | $961M | $961M | $961M | $960M | $310M | $687M | |
| Intangibles | $754M | $765M | $777M | $812M | $874M | $924M | $138M | $293M | |
| Other Non-current Assets | $138M | $129M | $103M | $81M | $119M | $118M | $88M | $83M | |
| Total Assets | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B | $3.66B | $2.27B | $2.39B | |
| Accounts Payable | $125M | $105M | $103M | $82M | $57M | $65M | $39M | $31M | |
| Accrued Liabilities | $94M | $77M | $97M | $106M | $98M | $135M | $97M | $90M | |
| Current Liabilities | $597M | $508M | $488M | $431M | $424M | $497M | $341M | $304M | |
| Capital Leases | $208M | $186M | $168M | $163M | $177M | $156M | $194M | $180M | |
| Deferred Tax | $62M | $32M | $30M | $26M | $26M | $27M | $25M | $25M | |
| Other Non-current Liabilities | $42M | $40M | $39M | $37M | $74M | $58M | $81M | $89M | |
| Total Liabilities | $1.57B | $1.32B | $1.37B | $1.35B | $1.54B | $2.37B | $959M | $1.09B | |
| Long-term Debt | $663M | $553M | $649M | $695M | $839M | $1.61B | $287M | $415M | |
| Total Debt | $663M | $553M | $649M | $695M | $839M | · | · | · | |
| Common Stock | $848.0K | $839.0K | $832.0K | $822.0K | $818.0K | $817.0K | $810.0K | $806.0K | |
| Retained Earnings | $3.03B | $2.78B | $2.54B | $2.40B | $2.31B | $1.96B | $1.97B | $2.03B | |
| Treasury Stock | $2.29B | $2.01B | $1.78B | $1.51B | $1.34B | $1.22B | $1.16B | $1.08B | |
| AOCI | $-2M | $-2M | $-2M | $-2M | $-2M | $-634.0K | $-8M | $-159M | |
| Stockholders' Equity | $1.45B | $1.43B | $1.37B | $1.46B | $1.49B | $1.28B | $1.31B | $1.29B | |
| Liabilities + Equity | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B | $3.66B | $2.27B | $2.39B | |
| Shares Outstanding | 34,033,000 | 35,952,000 | 37,681,000 | 82,232,000 | 81,796,000 | 81,705,000 | 81,021,000 | 52,953,000 |
Cashflow 16
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $42M | $26M | $14M | $23M | · | · | · | |
| Deferred Tax | $68M | $18M | $11M | $-5M | $-14M | · | · | · | |
| Amort. of Intangibles | $11M | $11M | $36M | $61M | $97M | · | · | · | |
| Restructuring | $6M | $3M | $2M | $19M | $26M | · | · | · | |
| Operating Cash Flow | $470M | $338M | $296M | $192M | $11M | · | · | · | |
| CapEx | $78M | $50M | $49M | $26M | $31M | · | · | · | |
| Investing Cash Flow | $-84M | $-42M | $-48M | $24M | $-552M | · | · | · | |
| Debt Issued | $1.01B | $10M | $2M | $0 | $850M | · | · | · | |
| Net Debt Issued | $112M | $-100M | $-50M | $-151M | $-230M | · | · | · | |
| Stock Repurchased | $240M | $213M | $262M | $123M | $120M | · | · | · | |
| Net Stock Activity | $-240M | $-213M | $-262M | $-123M | $-120M | · | · | · | |
| Financing Cash Flow | $-180M | $-316M | $-302M | $-289M | $-424M | · | · | · | |
| Net Change in Cash | $207M | $-20M | $-54M | $-73M | $-966M | · | · | · | |
| Taxes Paid | $14M | $33M | $31M | $12M | $94M | · | · | · | |
| Free Cash Flow | $393M | $288M | $247M | $166M | $-21M | · | · | · | |
| Levered FCF | $358M | $247M | $193M | $109M | $-106M | · | · | · |
Rentabilität 7
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 19.6% | 19.1% | 13.7% | 11.6% | 5.8% | · | · | · | |
| Net Margin | 12.9% | 13.3% | 8.6% | 6.4% | 22.9% | · | · | · | |
| Pretax Margin | 17.7% | 16.7% | 10.3% | 7.7% | -3.2% | · | · | · | |
| EBITDA Margin | 19.6% | 19.1% | 13.7% | 11.6% | 5.8% | · | · | · | |
| ROA | 8.7% | 8.6% | 4.9% | 3.3% | 9.7% | · | · | · | |
| ROE | 17.8% | 16.5% | 10.2% | 6.3% | 21.3% | · | · | · | |
| ROIC | 14.1% | 13.4% | 9.0% | 7.1% | 2.3% | · | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 0.8 | 0.9 | 1.1 | 1.3 | · | · | · | |
| Quick Ratio | 1.0 | 0.7 | 0.7 | 0.9 | 1.0 | · | · | · | |
| Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | · | · | · | |
| LT Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | · | · | · | |
| Interest Coverage | 8.4 | 6.5 | 3.4 | 2.7 | 0.6 | · | · | · |
Effizienz 2
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.6 | 0.5 | 0.4 | · | · | · | |
| Receivables Turnover | 12.6 | 13.4 | 14.1 | 16.2 | 16.1 | · | · | · |
Wachstumsraten 9
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.8% | 9.2% | 5.0% | 53.7% | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 9.0% | 20.8% | 18.8% | · | · | · | · | |
| Revenue CAGR 5Y | 16.8% | 15.6% | · | · | · | · | · | · | |
| EPS YoY | 13.9% | 82.3% | 65.4% | -68.1% | 372.8% | · | · | · | |
| EPS CAGR 3Y | 50.9% | -1.3% | 35.6% | · | · | · | · | · | |
| EPS CAGR 5Y | 38.9% | · | · | · | · | · | · | · | |
| Net Income YoY | 6.1% | 73.3% | 46.5% | -70.0% | 344.1% | · | · | · | |
| Net Income CAGR 3Y | 39.2% | -8.6% | 25.0% | · | · | · | · | · | |
| Net Income CAGR 5Y | 29.1% | · | · | · | · | · | · | · |
Bewertung (TTM) 13
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B | · | · | · | |
| Net Income TTM | $252M | $237M | $137M | $93M | $311M | · | · | · | |
| Market Cap | $4.24B | $4.57B | $2.57B | $1.45B | $1.63B | · | · | · | |
| Enterprise Value | $4.50B | $4.93B | $3.00B | $1.87B | $2.12B | · | · | · | |
| P/E | 17.7 | 20.6 | 20.1 | 16.8 | 5.6 | · | · | · | |
| P/S | 2.2 | 2.6 | 1.6 | 1.0 | 1.2 | · | · | · | |
| P/B | 2.9 | 3.2 | 1.9 | 1.0 | 1.1 | · | · | · | |
| P / Cash Flow | 9.0 | 13.5 | 8.7 | 7.2 | 155.9 | · | · | · | |
| P / FCF | 10.8 | 15.9 | 10.4 | 8.8 | -78.8 | · | · | · | |
| EV / EBITDA | 11.7 | 14.4 | 13.8 | 11.1 | 26.3 | · | · | · | |
| EV / FCF | 11.5 | 17.1 | 12.2 | 11.3 | -102.6 | · | · | · | |
| EV / Revenue | 2.3 | 2.8 | 1.9 | 1.3 | 1.5 | · | · | · | |
| Earnings Yield | 5.7% | 4.9% | 5.0% | 6.0% | 17.9% | · | · | · |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $501M | $487M | $503M | $462M | $457M | $466M | $448M | $417M | $410M | $413M | $393M | $369M | $365M | $369M | $363M | $354M | |
| Cost of Revenue | $217M | $211M | $205M | $201M | $199M | $200M | $187M | $186M | $183M | $175M | $172M | $169M | $164M | $166M | $159M | $160M | |
| SG&A Expense | $188M | $184M | $183M | $176M | $181M | $175M | $157M | $159M | $155M | $157M | $156M | $166M | $153M | $145M | $142M | $146M | |
| Operating Expenses | $406M | $396M | $392M | $377M | $380M | $376M | $344M | $347M | $341M | $351M | $335M | $341M | $325M | $310M | $317M | $331M | |
| Operating Income | $95M | $91M | $111M | $85M | $77M | $91M | $104M | $70M | $69M | $62M | $59M | $28M | $40M | $59M | $46M | $24M | |
| Interest Expense | $10M | $14M | $11M | $11M | $11M | $13M | $14M | $14M | $15M | $17M | $17M | $16M | $15M | $14M | $16M | $18M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | |
| Other Non-op | $3M | $232.0K | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $-1M | $761.0K | |
| Pretax Income | $88M | $78M | $102M | $77M | $69M | $79M | $92M | $58M | $56M | $48M | $45M | $15M | $28M | $49M | $29M | $7M | |
| Income Tax | $16M | $20M | $26M | $16M | $14M | $19M | $21M | $12M | $5M | $11M | $8M | $3M | $4M | $389.0K | $4M | $1M | |
| Net Income | $72M | $42M | $76M | $62M | $54M | $61M | $76M | $46M | $49M | $37M | $40M | $11M | $22M | $46M | $25M | $592.0K | |
| EPS (Basic) | $2.12 | $1.21 | $2.14 | $1.71 | $1.50 | $1.64 | $2.03 | $1.22 | $1.26 | $0.95 | $1.00 | $0.26 | $0.51 | $1.02 | $0.54 | $0.01 | |
| EPS (Diluted) | $2.06 | $1.20 | $2.11 | $1.67 | $1.43 | $1.59 | $1.98 | $1.18 | $1.23 | $0.93 | $0.98 | $0.25 | $0.51 | $1.00 | $0.53 | $0.01 | |
| Shares (Basic) | -71,074,000 | 34,283,000 | 35,725,000 | 36,111,000 | -75,211,000 | 37,140,000 | 37,435,000 | 37,721,000 | -80,571,000 | 38,713,000 | 39,872,000 | 41,399,000 | -91,043,000 | 45,125,000 | 45,425,000 | 45,274,000 | |
| Shares (Diluted) | -72,354,000 | 34,782,000 | 36,230,000 | 37,057,000 | -77,409,000 | 38,233,000 | 38,401,000 | 39,109,000 | -82,300,000 | 39,636,000 | 40,787,000 | 42,184,000 | -92,664,000 | 45,801,000 | 46,121,000 | 46,342,000 | |
| EBITDA | · | $91M | $111M | $85M | · | $91M | $104M | $70M | · | $62M | $59M | $28M | · | $59M | $46M | $23M |
Bilanz 27
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $406M | $147M | $56M | $265M | $200M | $219M | $194M | $265M | $219M | $180M | $183M | $262M | · | $315M | $208M | $328M | |
| Receivables | $167M | $173M | $160M | $192M | $143M | $160M | $144M | $169M | $124M | $138M | $131M | $145M | · | $111M | $97M | $109M | |
| Prepaid Expense | $75M | $79M | $81M | $106M | $69M | $66M | $65M | $79M | $70M | $59M | $58M | $61M | · | $103M | $114M | $128M | |
| Current Assets | $652M | $404M | $303M | $567M | $416M | $450M | $407M | $517M | $418M | $388M | $378M | $473M | · | $533M | $423M | $570M | |
| PP&E (Net) | $303M | $277M | $266M | $257M | $256M | $251M | $246M | $245M | $249M | $273M | $260M | $265M | · | $253M | $276M | $282M | |
| PP&E (Gross) | $686M | $649M | $627M | $608M | $598M | $583M | $583M | $574M | $575M | $600M | $605M | $609M | · | $583M | $621M | $646M | |
| Accum. Depreciation | $383M | $372M | $361M | $351M | $342M | $332M | $337M | $329M | $326M | $327M | $345M | $345M | · | $330M | $346M | $364M | |
| Goodwill | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | · | $961M | $961M | $961M | |
| Intangibles | $754M | $757M | $760M | $763M | $765M | $768M | $771M | $774M | $777M | $784M | $792M | $802M | · | $825M | $839M | $855M | |
| Other Non-current Assets | $138M | $137M | $135M | $129M | $129M | $120M | $113M | $108M | $103M | $68M | $66M | $68M | · | $68M | $117M | $121M | |
| Total Assets | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | $2.79B | $2.72B | $2.82B | $2.74B | $2.72B | $2.70B | $2.79B | · | $2.87B | $2.84B | $3.00B | |
| Accounts Payable | $125M | $97M | $103M | $105M | $105M | $99M | $67M | $91M | $103M | $92M | $88M | $77M | · | $73M | $71M | $64M | |
| Accrued Liabilities | $94M | $93M | $72M | $63M | $77M | $86M | $62M | $87M | $97M | $114M | $98M | $89M | · | $87M | $94M | $94M | |
| Current Liabilities | $597M | $580M | $443M | $577M | $508M | $541M | $385M | $551M | $488M | $509M | $399M | $496M | · | $438M | $371M | $491M | |
| Capital Leases | $208M | $202M | $191M | $188M | $186M | $193M | $182M | $162M | $168M | $160M | $169M | $161M | · | $164M | $166M | $165M | |
| Deferred Tax | $62M | $59M | $57M | $53M | $32M | $34M | $32M | $30M | $30M | $29M | $27M | $26M | · | $27M | $27M | $26M | |
| Other Non-current Liabilities | $42M | $37M | $41M | $38M | $40M | $37M | $35M | $35M | $39M | $48M | $41M | $37M | · | $33M | $62M | $63M | |
| Total Liabilities | $1.57B | $1.37B | $1.24B | $1.41B | $1.32B | $1.36B | $1.28B | $1.43B | $1.37B | $1.39B | $1.33B | $1.42B | · | $1.36B | $1.32B | $1.49B | |
| Long-term Debt | $663M | $499M | $504M | $553M | $553M | $552M | $650M | $649M | $649M | $648M | $696M | $696M | · | $694M | $694M | $742M | |
| Total Debt | · | $499M | $504M | $553M | · | $552M | $650M | $649M | · | $648M | $696M | $696M | · | $694M | $694M | $742M | |
| Common Stock | $848.0K | $847.0K | $847.0K | $847.0K | $839.0K | $839.0K | $839.0K | $838.0K | $832.0K | $831.0K | $831.0K | $826.0K | · | $822.0K | $822.0K | $821.0K | |
| Retained Earnings | $3.03B | $2.96B | $2.92B | $2.84B | $2.78B | $2.72B | $2.66B | $2.59B | $2.54B | $2.49B | $2.45B | $2.41B | · | $2.38B | $2.35B | $2.33B | |
| Treasury Stock | $2.29B | $2.29B | $2.22B | $2.05B | $2.01B | $1.94B | $1.87B | $1.83B | $1.78B | $1.77B | $1.68B | $1.61B | · | $1.43B | $1.39B | $1.34B | |
| AOCI | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $1.45B | $1.36B | $1.38B | $1.46B | $1.43B | $1.43B | $1.44B | $1.39B | $1.37B | $1.32B | $1.37B | $1.38B | $1.46B | $1.51B | $1.52B | $1.51B | |
| Liabilities + Equity | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | $2.79B | $2.72B | $2.82B | $2.74B | $2.72B | $2.70B | $2.79B | · | $2.87B | $2.84B | $3.00B | |
| Shares Outstanding | 34,033,000 | 34,023,000 | 34,654,000 | 36,324,000 | 35,952,000 | 36,512,000 | 37,289,000 | 37,716,000 | 37,681,000 | 37,765,000 | 39,526,000 | 40,401,000 | 82,232,000 | 44,232,000 | 45,443,000 | 45,396,000 |
Cashflow 14
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $10M | $13M | $8M | $10M | $10M | $11M | $9M | $7M | $6M | $6M | $7M | $3M | $3M | $2M | $6M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $7M | $8M | $9M | $11M | $12M | $14M | $16M | $19M | |
| Restructuring | $1M | $863.0K | $4M | $310.0K | $388.0K | $510.0K | $322.0K | $2M | $653.0K | $473.0K | $68.0K | $676.0K | $1M | $1M | $1M | $15M | |
| Operating Cash Flow | $124M | $186M | $30M | $131M | $60M | $208M | $-19M | $89M | $60M | $143M | $-18M | $95M | $42M | $108M | $-50M | $91M | |
| CapEx | $27M | $20M | $15M | $16M | $19M | $10M | $11M | $10M | $17M | $2M | $5M | $10M | $7M | $9M | $4M | $5M | |
| Investing Cash Flow | $-28M | $-20M | $-20M | $-16M | $-12M | $-10M | $-11M | $-10M | $-16M | $-2M | $-5M | $-10M | $-7M | $44M | $-7M | $-6M | |
| Debt Issued | $163M | $617M | · | · | $0 | $0 | $0 | $10M | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | $0 | · | · | · | $0 | · | · | · | $-101M | |
| Stock Repurchased | $0 | $68M | $165M | $8M | $67M | $72M | $41M | $33M | $12M | $90M | $70M | $90M | $78M | · | · | $0 | |
| Net Stock Activity | · | · | · | $-8M | · | · | · | $-33M | · | · | · | $-90M | · | · | · | · | |
| Financing Cash Flow | $163M | $-76M | $-218M | $-50M | $-68M | $-172M | $-42M | $-34M | $-11M | $-140M | $-56M | $-95M | $-78M | $-44M | $-63M | $-103M | |
| Net Change in Cash | $259M | $90M | $-208M | $65M | $-20M | $26M | $-71M | $46M | $34M | $1M | $-78M | $-11M | $-42M | $107M | $-120M | $-18M | |
| Free Cash Flow | · | · | · | $115M | · | · | · | $79M | · | · | · | $85M | · | · | · | $86M | |
| Levered FCF | · | · | · | $106M | · | · | · | $67M | · | · | · | $72M | · | · | · | $71M |
Rentabilität 7
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 18.8% | 22.1% | 18.5% | · | 19.4% | 23.2% | 16.8% | · | 15.0% | 14.9% | 7.6% | · | 16.1% | 12.7% | 6.5% | |
| Net Margin | · | 8.6% | 15.2% | 13.4% | · | 13.1% | 16.9% | 11.1% | · | 8.9% | 10.1% | 2.9% | · | 12.4% | 6.7% | 0.62% | |
| Pretax Margin | · | 16.0% | 20.2% | 16.6% | · | 17.0% | 20.6% | 14.0% | · | 11.6% | 11.6% | 4.0% | · | 13.3% | 7.7% | 1.9% | |
| EBITDA Margin | · | 18.8% | 22.1% | 18.5% | · | 19.4% | 23.2% | 16.8% | · | 15.0% | 14.9% | 7.6% | · | 16.1% | 12.7% | 6.5% | |
| ROA | · | 1.5% | 2.9% | 2.2% | · | 2.2% | 2.8% | 1.7% | · | 1.3% | 1.4% | 0.37% | · | 1.4% | 0.74% | 0.06% | |
| ROE | · | 3.0% | 5.4% | 4.3% | · | 4.4% | 5.4% | 3.3% | · | 2.6% | 2.8% | 0.74% | · | 3.1% | 1.7% | 0.16% | |
| ROIC | · | 3.6% | 4.4% | 3.4% | · | 3.5% | 3.8% | 2.7% | · | 2.4% | 2.4% | 1.1% | · | 2.7% | 1.8% | 0.87% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.7 | 0.7 | 1.0 | · | 0.8 | 1.1 | 0.9 | · | 0.8 | 0.9 | 1.0 | · | 1.2 | 1.1 | 1.2 | |
| Quick Ratio | · | 0.6 | 0.5 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 0.6 | 0.8 | 0.8 | · | 1.0 | 0.8 | 0.9 | |
| Debt / Equity | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | |
| LT Debt / Equity | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | 6.7 | 10.2 | 7.7 | · | 6.9 | 7.5 | 4.8 | · | 3.7 | 3.5 | 1.8 | · | 4.1 | 3.0 | 1.3 |
Effizienz 2
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | |
| Receivables Turnover | · | 2.9 | 3.3 | 2.6 | · | 3.1 | 3.3 | 2.7 | · | 3.3 | 3.4 | 2.9 | · | 3.6 | 3.9 | 2.6 |
Bewertung (TTM) 13
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $1.92B | $1.88B | $1.79B | · | $1.74B | $1.67B | $1.59B | · | $1.54B | $1.49B | $1.46B | · | $1.45B | $1.44B | $1.45B | |
| Net Income TTM | · | $241M | $275M | $245M | · | $220M | $199M | $134M | · | $133M | $121M | $82M | · | $79M | $381M | $374M | |
| Market Cap | · | $3.92B | $3.59B | $5.61B | · | $3.67B | $3.39B | $2.85B | · | $1.94B | $2.33B | $1.73B | · | $1.71B | $1.61B | $1.65B | |
| Enterprise Value | · | $4.27B | $4.03B | $5.90B | · | $4.01B | $3.84B | $3.23B | · | $2.41B | $2.84B | $2.16B | · | $2.09B | $2.10B | $2.07B | |
| P/E | · | 17.5 | 14.1 | 24.1 | · | 17.7 | 17.9 | 22.6 | · | 16.3 | 21.4 | 23.9 | · | 22.5 | 4.6 | 4.8 | |
| P/S | · | 2.0 | 1.9 | 3.1 | · | 2.1 | 2.0 | 1.8 | · | 1.3 | 1.6 | 1.2 | · | 1.2 | 1.1 | 1.1 | |
| P/B | · | 2.9 | 2.6 | 3.8 | · | 2.6 | 2.4 | 2.0 | · | 1.5 | 1.7 | 1.3 | · | 1.1 | 1.1 | 1.1 | |
| P / Cash Flow | · | · | · | 43.0 | · | · | · | 31.9 | · | · | · | 17.4 | · | · | · | 18.1 | |
| P / FCF | · | · | · | 49.0 | · | · | · | 36.1 | · | · | · | 20.5 | · | · | · | 19.3 | |
| EV / EBITDA | · | 46.8 | 36.3 | 69.0 | · | 44.3 | 37.0 | 46.0 | · | 39.0 | 48.5 | 76.8 | · | 35.1 | 45.6 | 89.6 | |
| EV / FCF | · | · | · | 51.5 | · | · | · | 41.0 | · | · | · | 25.6 | · | · | · | 24.1 | |
| EV / Revenue | · | 2.2 | 2.1 | 3.3 | · | 2.3 | 2.3 | 2.0 | · | 1.6 | 1.9 | 1.5 | · | 1.4 | 1.5 | 1.4 | |
| Earnings Yield | · | 5.7% | 7.1% | 4.2% | · | 5.6% | 5.6% | 4.4% | · | 6.2% | 4.7% | 4.2% | · | 4.5% | 21.9% | 20.8% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $1.95B | $1.79B | $1.58B | $1.45B | — |
| Betriebsgewinnmarge % | 19.6% | 19.1% | 13.7% | 11.6% | — |
| Nettoergebnis | $252M | $237M | $137M | $93M | — |
| Verwässerte EPS | $7.04 | $6.18 | $3.39 | $2.05 | — |
Bilanz
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.5 | 0.4 | 0.5 | 0.5 | — |
| Liquiditätsgrad | 1.1 | 0.8 | 0.9 | 1.1 | — |
| Quick Ratio | 1.0 | 0.7 | 0.7 | 0.9 | — |
Cashflow
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $393M | $288M | $247M | $166M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 402 Einreicher · $3.0B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 61 (+15 vs. Vorquartal) | 30 (-23 vs. Vorquartal) | 137 (+3 vs. Vorquartal) | 121 (-7 vs. Vorquartal) | +4.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $418.746.711 | 4.047.035 | 14,07% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $297.558.184 | 2.386.958 | 10,00% | Aktien |
| FMR LLC | $280.021.015 | 2.246.278 | 9,41% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $208.992.241 | 1.676.499 | 7,02% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $183.742.358 | 1.473.948 | 6,17% | Aktien |
| STATE STREET CORP | $173.212.203 | 1.389.477 | 5,82% | Aktien |
| Capital World Investors | $132.593.736 | 1.063.643 | 4,46% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $95.719.361 | 767.678 | 3,22% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $87.910.731 | 705.204 | 2,95% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $78.581.301 | 630.365 | 2,64% | Aktien |
| Alyeska Investment Group, L.P. | $68.807.458 | 551.961 | 2,31% | Aktien |
| Fisher Asset Management, LLC | $63.050.035 | 505.776 | 2,12% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60.245.186 | 483.276 | 2,02% | Aktien |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | $44.010.839 | 353.047 | 1,48% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $37.728.848 | 302.654 | 1,27% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $32.342.164 | 259.443 | 1,09% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $30.437.360 | 244.163 | 1,02% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $26.065.659 | 209.094 | 0,88% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $23.386.341 | 187.601 | 0,79% | Aktien |
| SG Capital Management LLC | $22.238.845 | 178.396 | 0,75% | Aktien |
| TWO SIGMA ADVISERS, LP | $19.876.587 | 192.100 | 0,67% | Aktien |
| ALGERT GLOBAL LLC | $19.323.048 | 155.006 | 0,65% | Aktien |
| MORGAN STANLEY | $18.731.418 | 150.260 | 0,63% | Aktien |
| Public Sector Pension Investment Board | $17.393.810 | 139.530 | 0,58% | Aktien |
| Corient Private Wealth LP | $16.950.396 | 135.973 | 0,57% | Aktien |
| WESTPORT ASSET MANAGEMENT INC | $15.677.117 | 125.759 | 0,53% | Aktien |
| Bank of New York Mellon Corp | $15.262.248 | 122.431 | 0,51% | Aktien |
| PRUDENTIAL FINANCIAL INC | $14.091.816 | 113.042 | 0,47% | Aktien |
| MACKENZIE FINANCIAL CORP | $13.510.152 | 108.376 | 0,45% | Aktien |
| Qube Research & Technologies Ltd | $12.647.380 | 101.455 | 0,43% | Aktien |
| BANK OF AMERICA CORP /DE/ | $12.502.650 | 100.294 | 0,42% | Aktien |
| RHUMBLINE ADVISERS | $10.647.181 | 85.410 | 0,36% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $9.671.247 | 77.581 | 0,33% | Aktien |
| Foresight Group Ltd Liability Partnership | $9.636.366 | 77.264 | 0,32% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $9.436.388 | 75.697 | 0,32% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $8.879.782 | 77.048 | 0,30% | Aktien |
| BlackRock, Inc. | $8.832.036 | 70.849 | 0,30% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $8.696.157 | 69.759 | 0,29% | Aktien |
| Swiss National Bank | $8.638.938 | 69.300 | 0,29% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $8.557.000 | 68.639 | 0,29% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $8.419.536 | 67.540 | 0,28% | Aktien |
| Hillsdale Investment Management Inc. | $8.077.968 | 64.800 | 0,27% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $8.030.847 | 64.422 | 0,27% | Aktien |
| RENAISSANCE GROUP LLC | $7.608.748 | 61.036 | 0,26% | Aktien |
| AMERIPRISE FINANCIAL INC | $7.563.622 | 60.674 | 0,25% | Aktien |
| GOLDMAN SACHS GROUP INC | $7.528.716 | 60.394 | 0,25% | Aktien |
| Allianz Asset Management GmbH | $7.053.013 | 56.578 | 0,24% | Aktien |
| LONESTAR CAPITAL MANAGEMENT LLC | $6.856.300 | 55.000 | 0,23% | Aktien |
| Legal & General Group Plc | $6.503.387 | 52.169 | 0,22% | Aktien |
| Phocas Financial Corp. | $6.345.443 | 50.902 | 0,21% | Aktien |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $6.335.869 | 54.975 | 0,21% | Aktien |
| FIRST TRUST ADVISORS LP | $6.152.968 | 49.358 | 0,21% | Aktien |
| ExodusPoint Capital Management, LP | $5.906.141 | 47.378 | 0,20% | Aktien |
| KESTREL INVESTMENT MANAGEMENT CORP | $5.896.418 | 47.300 | 0,20% | Aktien |
| LEUTHOLD GROUP, LLC | $5.622.914 | 45.106 | 0,19% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $5.482.297 | 43.978 | 0,18% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $5.313.757 | 42.626 | 0,18% | Aktien |
| LGT Fund Management Co Ltd. | $4.992.633 | 40.050 | 0,17% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4.840.500 | 42.000 | 0,16% | Aktien |
| Trexquant Investment LP | $4.814.120 | 38.618 | 0,16% | Aktien |
| FARLEY CAPITAL L.P. | $4.644.333 | 37.256 | 0,16% | Aktien |
| SEI INVESTMENTS CO | $4.541.490 | 36.431 | 0,15% | Aktien |
| CHURCHILL MANAGEMENT Corp | $4.474.806 | 35.171 | 0,15% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $4.270.726 | 34.259 | 0,14% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $3.909.088 | 31.358 | 0,13% | Aktien |
| HSBC HOLDINGS PLC | $3.726.330 | 29.614 | 0,13% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $3.568.268 | 28.624 | 0,12% | Aktien |
| Smith Group Asset Management, LLC | $3.304.113 | 26.505 | 0,11% | Aktien |
| OP Asset Management Ltd | $3.295.387 | 26.435 | 0,11% | Aktien |
| Horizon Investments, LLC | $3.257.730 | 21.000 | 0,11% | Aktien |
| Atom Investors LP | $3.165.242 | 25.391 | 0,11% | Aktien |
| FORMULA GROWTH LTD | $3.140.933 | 25.196 | 0,11% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.064.891 | 24.586 | 0,10% | Aktien |
| BARCLAYS PLC | $2.926.019 | 23.472 | 0,10% | Aktien |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $2.840.627 | 22.787 | 0,10% | Aktien |
| NewEdge Wealth, LLC | $2.790.514 | 22.385 | 0,09% | Aktien |
| Elo Mutual Pension Insurance Co | $2.724.943 | 21.859 | 0,09% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $2.717.588 | 21.800 | 0,09% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $2.695.523 | 21.623 | 0,09% | Aktien |
| MetLife Investment Management, LLC | $2.499.807 | 20.053 | 0,08% | Aktien |
| Global Alpha Capital Management Ltd. | $2.430.995 | 19.501 | 0,08% | Aktien |
| FIFTH THIRD BANCORP | $2.403.502 | 19.280 | 0,08% | Aktien |
| ROYCE & ASSOCIATES LP | $2.376.768 | 19.066 | 0,08% | Aktien |
| Boston Partners | $2.293.116 | 18.393 | 0,08% | Aktien |
| Quantinno Capital Management LP | $2.288.134 | 18.355 | 0,08% | Aktien |
| Grantham, Mayo, Van Otterloo & Co. LLC | $2.256.097 | 18.098 | 0,08% | Aktien |
| LGT CAPITAL PARTNERS LTD. | $2.206.482 | 17.700 | 0,07% | Aktien |
| IEQ CAPITAL, LLC | $2.199.751 | 17.646 | 0,07% | Aktien |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $2.141.829 | 20.700 | 0,07% | Aktien |
| Bridgewater Associates, LP | $2.138.044 | 17.151 | 0,07% | Aktien |
| CITIGROUP INC | $2.106.879 | 16.901 | 0,07% | Aktien |
| CITADEL ADVISORS LLC | $2.106.754 | 16.900 | 0,07% | Kaufoption |
| Banque Cantonale Vaudoise | $2.082.000 | 16.700 | 0,07% | Aktien |
| Mariner, LLC | $2.075.942 | 16.653 | 0,07% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2.064.120 | 16.558 | 0,07% | Aktien |
| Illinois Municipal Retirement Fund | $2.054.147 | 16.478 | 0,07% | Aktien |
| Gotham Asset Management, LLC | $2.014.256 | 16.158 | 0,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.982.094 | 15.900 | 0,07% | Kaufoption |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.977.731 | 15.865 | 0,07% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1.902.312 | 15.260 | 0,06% | Aktien |
Unternehmensinsider 111 Insider · 46 Führungskräfte · 24 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Daniel Hamburger | President and CEO | 31. August 2015 S | 142.136 | 0 | 0 | $0 |
| Michael O Randolfi | SVP, Chief Financial Officer | 28. August 2020 F | 84.391 | 0 | 0 | $0 |
| Timothy J Wiggins | SVP & Chief Financial Officer | 25. Februar 2016 S | 44.939 | 0 | 0 | $0 |
| Richard Gunst | Chief Financial Officer | 1. Februar 2012 M | 9.356 | 0 | 0 | $0 |
| Amelia Manning | President, Chamberlain Univ. | 15. Juli 2026 A | 4.317 | 0 | 0 | $0 |
| Karen Sue Cox | President, Chamberlain Univ. | 8. Mai 2026 S | 31.596 | 0 | 1 | $-249.000 |
| Scott Liles | President, Medical and Vet | 15. April 2026 F | 13.103 | 0 | 0 | $0 |
| Evan Trent | President, Adtalem Elevate | 13. November 2025 F | 24.134 | 0 | 0 | $0 |
| Thiago Aguiar Sayao | Group President, Business &Law | 28. Februar 2020 S | 1.830 | 0 | 0 | $0 |
| Carlos Filgueiras | Group President, Tech/Business | 13. Februar 2019 S | 11.775 | 0 | 0 | $0 |
| Donna M Loraine | President, Carrington Colleges | 6. November 2018 M | 6.701 | 0 | 0 | $0 |
| Susan Groenwald | President, Chamberlain | 9. Februar 2018 M | 34.402 | 0 | 0 | $0 |
| John P Roselli | President, Becker Professional | 1. September 2017 S | 13.730 | 0 | 0 | $0 |
| Eric P. Dirst | President, ATGE Shared Ops | 31. August 2017 S | 14.800 | 0 | 0 | $0 |
| Robert A Paul | President, DeVry University | 25. August 2017 M | 28.426 | 0 | 0 | $0 |
| Steven Riehs | President, Med, Prof & Online | 2. September 2016 M | 28.062 | 0 | 0 | $0 |
| Jeffrey Richard Akens | President, Carrington College | 29. August 2015 F | 6.752 | 0 | 0 | $0 |
| Christopher Caywood | President, Online Services | 1. März 2013 F | 7.378 | 0 | 0 | $0 |
| Andrew A Jeon | President, DeVry Medical Int'l | 2. November 2012 F | 5.655 | 0 | 0 | $0 |
| William B. Hughson | President, Medical & | 29. August 2012 A | 2.143 | 0 | 0 | $0 |
| Manjunath Gangadharan | VP, Chief Accounting Officer | 18. Mai 2026 F | 5.271 | 0 | 1 | $-128.072 |
| Michael Betz | Pres. Walden University & CDO | 13. November 2025 F | 33.286 | 0 | 0 | $0 |
| Maurice Herrera | SVP - Chief Marketing Officer | 13. November 2025 F | 20.584 | 0 | 0 | $0 |
| Megan Noel | Chief Corp. Affairs Officer | 12. November 2025 A | 2.226 | 0 | 0 | $0 |
| Sara Hill | CHRO | 12. November 2025 A | 10.276 | 0 | 0 | $0 |
| Blake Simpson | SVP, Chief Comms & CA Officer | 5. Dezember 2024 F | 8.795 | 0 | 0 | $0 |
| Steven Tom | SVP Chief Customer Officer | 13. November 2024 A | 13.255 | 0 | 0 | $0 |
| Cheryl James | SVP, CHRO | 28. Februar 2024 F | 17.485 | 0 | 0 | $0 |
| John W Danaher MD | Pres. - Adtalem Med & Vet | 25. August 2023 F | 38.718 | 0 | 0 | $0 |
| James Raymond Bartholomew | SVP - Chamberlain University | 26. August 2022 F | 6.418 | 0 | 0 | $0 |
| Holland Katherine Alice Boden | Group Pres, Adtalem Health | 30. August 2021 F | 32.148 | 0 | 0 | $0 |
| Fernando Lau | SVP, Chief Marketing Officer | 28. August 2021 F | 19.253 | 0 | 0 | $0 |
| Christopher C Nash | SVP, Chief Information Officer | 28. August 2021 F | 25.741 | 0 | 0 | $0 |
| Donna Jennings | SVP, Human Resources | 28. August 2021 F | 30.898 | 0 | 0 | $0 |
| Chaka M Patterson | SVP and General Counsel | 28. August 2020 F | 5.202 | 0 | 0 | $0 |
| Mehul R Patel | Group Pres, Financial Services | 7. November 2019 F | 11.258 | 0 | 0 | $0 |
| Kathleen Carroll | Vice President, Controller | 28. August 2019 A | 5.497 | 0 | 0 | $0 |
| Lisa M Sodeika | SVP, Corporate Affairs | 28. August 2019 A | 24.151 | 0 | 0 | $0 |
| Patrick J Unzicker | Principal Financial Officer | 27. August 2019 F | 36.360 | 0 | 0 | $0 |
| Catherine C. Anderson | SVP, Strategy & Innovation | 26. August 2019 F | 6.025 | 0 | 0 | $0 |
| Gena L Ashe | SVP, CLO and Secretary | 23. August 2017 A | 4.420 | 0 | 0 | $0 |
| Gregory S Davis | SVP and General Counsel | 1. September 2016 S | 22.433 | 0 | 0 | $0 |
| Adriano Allegrini | VP, Strategy and Bus. Develop. | 29. August 2015 F | 7.004 | 0 | 0 | $0 |
| Sharon Thomas Parrott | SVP, Gov. & Regulatory Affairs | 5. November 2014 A | 5.610 | 0 | 0 | $0 |
| David J Pauldine | Executive Vice President & | 25. April 2014 M | 30.242 | 0 | 0 | $0 |
| Thomas C Shepherd | Executive Vice President and | 27. Mai 2011 M | 0 | 0 | 0 | $0 |
| Michael W Malafronte | Direktor | 11. März 2026 P | 25.395 | 5 | 0 | $3.844.716 |
| William V Krehbiel | Direktor | 13. November 2025 F | 16.303 | 0 | 0 | $0 |
| Betty M. Vandenbosch | Direktor | 13. November 2025 F | 2.584 | 0 | 0 | $0 |
| Kenneth J Phelan | Direktor | 13. November 2025 F | 19.836 | 1 | 0 | $49.931 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| International Value Advisers, LLC, Charles de Vaulx ×18 Einreichungen | 7. August 2020 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 79 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PSCD · Invesco Exchange-Traded Fund Trust … | 1,82% | 3.165 SH | 8. August 2026 | Täglich |
| PSL · Invesco Exchange-Traded Fund Trust | 1,76% | 10.579 SH | 8. August 2026 | Täglich |
| MYLD · Cambria ETF Trust | 0,94% | 2.418 NS | 30. April 2026 | N-PORT |
| XSHQ · Invesco Exchange-Traded Fund Trust … | 0,91% | 20.685 SH | 8. August 2026 | Täglich |
| RZG · Invesco Exchange-Traded Fund Trust | 0,88% | 8.705 SH | 8. August 2026 | Täglich |
| CGMM · Capital Group Equity ETF Trust I | 0,80% | 190.016 NS | 31. Mai 2026 | N-PORT |
| VUSE · ETF Series Solutions | 0,53% | 31.159 NS | 31. Mai 2026 | N-PORT |
| IJT · iShares Trust | 0,47% | 316.256 SH | 8. August 2026 | Täglich |
| CAFG · Pacer Funds Trust | 0,47% | 919 NS | 30. April 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,46% | 40.509 SH | 8. August 2026 | Täglich |
| CALF · Pacer Funds Trust | 0,46% | 136.827 NS | 30. April 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,33% | 29.825 NS | 30. April 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,27% | 4.982 SH | 8. August 2026 | Täglich |
| XJR · iShares Trust | 0,26% | 4.021 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,26% | 312.826 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,26% | 52.359 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,25% | 36.861 SH | 8. August 2026 | Täglich |
| IJR · iShares Trust | 0,23% | 2.075.461 SH | 8. August 2026 | Täglich |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,23% | 119.030 SH | 8. August 2026 | Täglich |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 10.711 NS | 30. April 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,21% | 4.228 SH | 8. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 13.071 NS | 30. April 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,20% | 2.228 NS | 30. April 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,20% | 46.807 NS | 31. Mai 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,18% | 1.290 NS | 30. April 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,18% | 217.961 NS | 30. April 2026 | N-PORT |
| SAA · ProShares Trust | 0,18% | 412 NS | 31. Mai 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,14% | 29.761 NS | 30. April 2026 | N-PORT |
| GMOV · GMO ETF Trust | 0,14% | 1.078 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,13% | 875.500 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,13% | 10.563 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,13% | 198.216 SH | 8. August 2026 | Täglich |
| FNDA · SCHWAB STRATEGIC TRUST | 0,13% | 98.138 NS | 31. Mai 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,13% | 19.006 SH | 8. August 2026 | Täglich |
| SMLF · iShares Trust | 0,12% | 41.596 SH | 8. August 2026 | Täglich |
| VFQY · VANGUARD WELLINGTON FUND | 0,12% | 4.599 SH | 8. August 2026 | Täglich |
| PKW · Invesco Exchange-Traded Fund Trust | 0,12% | 15.066 SH | 8. August 2026 | Täglich |
| VCR · VANGUARD WORLD FUND | 0,12% | 67.714 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,12% | 14.797 NS | 30. April 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,11% | 12.017 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,11% | 9.365 NS | 31. Mai 2026 | N-PORT |
| FDIS · FIDELITY COVINGTON TRUST | 0,10% | 15.550 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,10% | 1.606 NS | 31. Mai 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,10% | 5.421 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,09% | 111.249 NS | 30. April 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,09% | 470.701 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,09% | 165.865 NS | 31. Mai 2026 | N-PORT |
| ESML · iShares Trust | 0,07% | 16.803 SH | 8. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 2.779 NS | 30. April 2026 | N-PORT |
| ISCB · iShares Trust | 0,06% | 1.479 SH | 8. August 2026 | Täglich |